| Just Answers |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Writing and Speaking > Writing and Speaking > Hero's Journey (Monomyth) : Shape Shifter |
|
Just Answers - Hero's Journey (Monomyth) : Shape Shifter
The Hero's Journey is the template upon which the vast majority of s According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product uccessful stories and Hollywood blockbusters are based upon. In fact ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in , ALL of the Hollywood movies we have deconstructed (see URL below) lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. are based on this 188 stage template. Understanding this templat here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe e is a priority for story or screenwriters. There is only on d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro e story. The Hero's Journey: a) Attempts to tap into un ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc conscious expectations the audience has regarding what a story is an easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi how it should be told. b) Gives the writer more structural element nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically s than simply three or four acts, plot points, mid point and so on. and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ c) Gives you a tangible process for building and releasing dissonan ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ce (establishing and achieving catharsis). d) Gives you a universal ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a structural template upon which you can superimpose your situational dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod story. and more... Shape Shifter One critical element of cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin most stories is the presence of a Shape Shifter. This is an archetyp tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen that turns from good to bad or vice versa. This is seen in many of t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel the most successful stories of our time: a) In The Matrix (1999), C ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ypher gives away Neo to Smith for the blessing of ignorance. b) In y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products Gladiator (2000), Lucilla switches from pro-Commodus to pro-Maximus. . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de c) In Departed (2006), Dignam is initially contemptuous of Billy a elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip nd a good cop, only to illegally shoot COlin in the closing sequence tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Imagery & Affirmations - Changing Habits Payment Protection Inurance in the UK - the Truths and the Mistruths Everything A Real Estate Agent Doesn't Want You To Know, A Year In Review 2006
|